-
CEL-SCI, University of Georgia to Develop LEAPS COVID-19 Immunotherapy
americanpharmaceuticalreview
March 24, 2020
CEL-SCI has signed a collaboration agreement with the University of Georgia’s Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy.
-
CEL-SCI to develop Covid-19 immunotherapy
pharmaceutical-technology
March 12, 2020
Biotechnology company CEL-SCI has begun efforts to develop an immunotherapy for the potential treatment of Covid-19 coronavirus infection.
-
CEL-SCI Developing Immunotherapy to Treat Coronavirus
contractpharma
March 10, 2020
Will leverage LEAPS peptide technology to reduce COVID-19 viral load and tissue damage resulting from infection in the lungs.
-
B cells linked to effective cancer immunotherapy
worldpharmanews
January 19, 2020
Cancer patients responded better to immunotherapy and had a better prognosis if their melanoma tumours contained specific clusters of B cells, according to new research from Lund University in Sweden.
-
IFM Due signs immunotherapy deal with Novartis
pharmaceutical-technology
September 10, 2019
IFM Due, a subsidiary of IFM Therapeutics, has entered a collaboration and exclusive option agreement with Novartis...
-
Study shows the potential to deliver immunotherapy directly to brain tumours
europeanpharmaceuticalreview
September 02, 2019
New nano-immunotherapy has traversed the blood-brain barrier in mice, inducing an immune response in brain tissue surrounding tumours.
-
2019 China Cancer Immunotherapy Workshop Successfully Held
chinadaily
July 23, 2019
2019 China Cancer Immunotherapy Workshop was successfully held on June 29- 30, 2019 in Tianjin, China. The Workshop was organized by China Center for Food and Drug International Exchange(CCFDIE) ...
-
Immunotherapy specialist benefits from Quantum bioprocessing pump
europeanpharmaceuticalreview
July 18, 2019
Quantum pump specified for critical UF/DF processes; user says “no other pump could meet all of our needs”.
-
Should You Try Allergen Immunotherapy?
drugs
July 10, 2019
If you're constantly sneezing and sniffling even though you take allergy medication to relieve symptoms, you may want to consider immunotherapy.
-
Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
En-CPhI.cn
June 24, 2019
Preliminary data shows a high response rate, with 16 of 16 patients achieving complete remission and 14 of 16 patients achieving undetectable minimal residual disease with mild side effect observed